|
|
Volumn 30, Issue 5, 1998, Pages 2179-2181
|
|
Five-year follow-up of tacrolimus as primary immunosuppressant after liver transplantation
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACICLOVIR;
AZATHIOPRINE;
COTRIMOXAZOLE;
CYCLOSPORIN A;
HYPERIMMUNE GLOBULIN;
METHYLPREDNISOLONE;
PENTAMIDINE;
PREDNISOLONE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ADULT;
ALCOHOL ABUSE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FOLLOW UP;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEPATITIS B;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION COMPLICATION;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER CELL CARCINOMA;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
ORAL DRUG ADMINISTRATION;
PNEUMOCYSTIS PNEUMONIA;
PRIORITY JOURNAL;
RECURRENCE RISK;
SURVIVAL RATE;
TREATMENT INDICATION;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
AZATHIOPRINE;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FOLLOW-UP STUDIES;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
METHYLPREDNISOLONE;
MIDDLE AGED;
NEOPLASMS;
POSTOPERATIVE COMPLICATIONS;
SURVIVAL RATE;
TACROLIMUS;
TIME FACTORS;
|
|
EID: 13144276337
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)00580-6 Document Type: Conference Paper |
|
Times cited : (5)
|
|
References (7)
|
